VCIM
XFOR icon

Velan Capital Investment Management’s X4 Pharmaceuticals XFOR Stock Holding History

Velan Capital Investment Management’s Portfolio XFOR Stock Details XFOR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-21,967
Closed -$382K – 21
2024
Q2 		$382K Buy
+21,967
New +$718K 0.22% 16

Other funds holding XFOR

BCLSI
Bain Capital Life Sciences Investors Boston, Massachusetts $1.11B AUM 171.34% 1-Year Est. Return
NMC
NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
KCM
Kingdon Capital Management New York $911M AUM 51.11% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Axa
Axa Paris, France $256M AUM 25.01% 1-Year Est. Return

Velan Capital Investment Management's XFOR Position: Q3 2024 in Review

Velan Capital Investment Management sold out of X4 Pharmaceuticals (XFOR) in Q3 2024, closing a stake of 21,967 shares — an estimated $382K sold.

Velan Capital Investment Management first reported a position in XFOR in Q2 2024 and held it in 1 quarter. The position peaked at $382K in Q2 2024. 97 funds tracked by Wall St. Rank hold XFOR as of Q3 2024.

  • Velan Capital Investment Management reported no remaining X4 Pharmaceuticals position as of Q3 2024 after selling out during the quarter.
  • Velan Capital Investment Management sold 21,967 X4 Pharmaceuticals shares in Q3 2024, an estimated $382K.
  • Velan Capital Investment Management first reported a position in X4 Pharmaceuticals in Q2 2024 and held it in 1 quarter.
  • Velan Capital Investment Management's X4 Pharmaceuticals position peaked at $382K in Q2 2024.
  • 97 funds tracked by Wall St. Rank held X4 Pharmaceuticals as of Q3 2024.

Based on Velan Capital Investment Management's 13F filing for Q3 2024, filed 14 Nov 2024.